Expensive AstraZeneca COVID-19 Vaccine May Happen as Expert Says Manufacturer Didn't Make Much Profit Expensive AstraZeneca COVID-19 could be a reality! Here's why the manufacturer suddenly wants to make a profit from its medicine. by Griffin Davis